Empathogen

Ecstasy monogram

Empathogen is a term used to describe a class of psychoactive drugs that produce experiences of emotional communion, oneness, relatedness, emotional openness—that is, empathy or sympathy. These substances are also known as entactogens, a term that emphasizes the introspective and self-exploratory effects of these drugs.

History

The term "empathogen" was coined in the 1980s by Ralph Metzner to describe the unique effects of these substances. The most well-known empathogen is MDMA (3,4-methylenedioxymethamphetamine), commonly known as ecstasy. MDMA was first synthesized in 1912 by the German pharmaceutical company Merck, but its psychoactive properties were not discovered until the 1970s.

Pharmacology

Empathogens primarily act on the serotonin system in the brain. They increase the release of serotonin and inhibit its reuptake, leading to elevated levels of serotonin in the synaptic cleft. This action is believed to be responsible for the mood-lifting and empathogenic effects of these drugs. Some empathogens also affect the release of other neurotransmitters such as dopamine and norepinephrine.

Effects

The effects of empathogens can vary depending on the specific substance, dosage, and individual. Common effects include:

• Increased empathy and emotional closeness
• Enhanced mood and well-being
• Increased sociability and talkativeness
• Altered perception of time
• Mild hallucinations (in higher doses)

Risks and Side Effects

While empathogens can have therapeutic potential, they also carry risks. Common side effects include:

• Increased heart rate and blood pressure
• Jaw clenching and teeth grinding
• Nausea
• Anxiety and paranoia (in higher doses)
• Potential for neurotoxicity with repeated use

Therapeutic Use

Empathogens, particularly MDMA, have been studied for their potential in psychotherapy. MDMA-assisted psychotherapy has shown promise in the treatment of post-traumatic stress disorder (PTSD) and other mental health conditions. The Multidisciplinary Association for Psychedelic Studies (MAPS) has been at the forefront of this research.

Legal Status

The legal status of empathogens varies by country. In many places, substances like MDMA are classified as Schedule I drugs, meaning they are considered to have a high potential for abuse and no accepted medical use. However, there is ongoing research and advocacy for the reclassification of these substances to allow for medical and therapeutic use.

Related Pages

• MDMA
• Psychedelic therapy
• Serotonin
• Dopamine
• Norepinephrine
• Post-traumatic stress disorder
• Multidisciplinary Association for Psychedelic Studies

See Also

• Psychedelic drug
• Entactogen
• Hallucinogen
• Psychotherapy

This psychoactive drug related article is a stub.